- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Clear All
Trial Details
Key Eligibility Criteria
275 Participants Needed
Trial Details
Key Eligibility Criteria
48 Participants Needed
Trial Details
Key Eligibility Criteria
193 Participants Needed
Trial Details
Key Eligibility Criteria
8300 Participants Needed
Trial Details
Key Eligibility Criteria
505 Participants Needed
Trial Details
Key Eligibility Criteria
474 Participants Needed
Trial Details
Key Eligibility Criteria
480 Participants Needed
Trial Details
Key Eligibility Criteria
300 Participants Needed
Trial Details
Key Eligibility Criteria
544 Participants Needed
Trial Details
Key Eligibility Criteria
731 Participants Needed
Trial Details
Key Eligibility Criteria
668 Participants Needed
Trial Details
Key Eligibility Criteria
10000 Participants Needed
Trial Details
Key Eligibility Criteria
64 Participants Needed
Trial Details
Key Eligibility Criteria
6452 Participants Needed
Trial Details
Key Eligibility Criteria
427 Participants Needed
Trial Details
Key Eligibility Criteria
345 Participants Needed
Trial Details
Key Eligibility Criteria
5 Participants Needed
Trial Details
Key Eligibility Criteria
151 Participants Needed
Trial Details
Key Eligibility Criteria
42 Participants Needed
Trial Details
Key Eligibility Criteria
170 Participants Needed
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I've had radiation and as far as I know I’m in remission, but my brother passed away with the same condition. I don’t mind helping research for a cure... my husband passed away with pancreatic cancer. I've had a stepdaughter that passed away with ovarian cancer at 20. I just think it’s time to knock cancer out! I'd really like to help find better treatments by participating in a trial."
"My mom has cholangiocarcinoma with bone mts (FGFR2 mutation). She really needs this trial to survive. She’s active and her analysis is ok, but we have very limited other options. Hope to work with a high-quality clinic to prolong her quality and duration of life."
"I've tried chemotherapy and radiation but the cancer recurred. My oncologist suggested that I might want to try a clinical trial given my situation. Just starting to research, hoping to learn more."
"I had two chemotherapy regímens without success, three surgeries during which the tumor could not be resected. These clinical trials are a light of hope for me and my family (I have a five year old child) and I have read about cases of success in other types of cancer with this treatment. I think that I am a perfect candidate for this tríal. Thank you."
Trial Details
Key Eligibility Criteria
15 Participants Needed
Trial Details
Key Eligibility Criteria
240 Participants Needed
Trial Details
Key Eligibility Criteria
1250 Participants Needed
Trial Details
Key Eligibility Criteria
550 Participants Needed
Trial Details
Key Eligibility Criteria
222 Participants Needed
Trial Details
Key Eligibility Criteria
94 Participants Needed
Trial Details
Key Eligibility Criteria
104 Participants Needed
Trial Details
Key Eligibility Criteria
160 Participants Needed
Trial Details
Key Eligibility Criteria
60 Participants Needed
Trial Details
Key Eligibility Criteria
138 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Lung Cancer trials in High Point, NC 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in High Point, NC for Lung Cancer is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in High Point, NC several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added Niraparib + Temozolomide for Small Cell Lung Cancer, SHAREDCare Plan for Lung Cancer Survivors and Adagrasib + Pembrolizumab for Non-Small Cell Lung Cancer to the Power online platform.